About Us
Shanghai Kepeixing Biomedical Research Co., Ltd. is a contract research organization dedicated to pharmaceutical research and clinical studies, serving global biopharmaceutical companies and research institutions. We focus on providing professional clinical research services for innovative drugs, biopharmaceuticals, chemical drugs, traditional Chinese medicine, and vaccines, mainly providing full process clinical services including clinical operations, medical research, data statistics, drug vigilance, and registration applications. The company is equipped with a professional, meticulous, and experienced clinical research team, adhering to the business philosophy of "professionalism as the foundation, quality as the threshold, and service as the standard", with the mission of "providing partners with refined, experiential, and customized pharmaceutical research and clinical research services with the highest cost-effectiveness", and striving to achieve the beautiful vision of "becoming a leading clinical service brand in the industry".
Clinical research contract research
Clinical research site management
Recruitment of clinical research subjects
Clinical Trial Cloud Platform
Six major services
Pre IND application, IND application and initiation preparation, research implementation, listing application, post listing research
Professional field
Shanghai Kepeixing Biomedical Research Co., Ltd. is a company dedicated to pharmaceutical research and clinical studies. Focusing on professional services for clinical research of innovative drugs, biopharmaceuticals, chemical drugs, traditional Chinese medicine, and vaccines.
Seven supporting services around pharmaceutical re
We provide seven supporting services around pharmaceutical research and clinical studies.
News
Here, learn about the recent developments or news of Shanghai Kepei Xing Biomedical Research Co., Ltd.
300+
cooperative partner
Complementary advantages, joint construction and sharing, openness and win-win, and growing together with more outstanding enterprises.